PRESS RELEASE European Commission Approves Genzyme’s Multiple Sclerosis

First Page		Document Content
Date: 2013-09-17 12:37:08 Immunology Biology Alemtuzumab Genzyme Sanofi Interferon beta-1a CD52 Interferon Therapies under investigation for multiple sclerosis Multiple sclerosis Cytokines Immune system		PRESS RELEASE European Commission Approves Genzyme’s Multiple Sclerosis Add to Reading List Source URL: en.sanofi.com Download Document from Source Website File Size: 83,00 KB Share Document on Facebook

	United States Court of Appeals For the First Circuit NoANITA HOCHENDONER ET AL., Plaintiffs, Appellants, v. DocID: 1rtqA - View Document
	PRESS RELEASE For Canadian media only Sanofi to Return Allerject® (epinephrine injection, USP) Rights to kaléo Laval, Qc. - February 23, Sanofi (EURONEXT : SAN and NYSE : SNY) announced today DocID: 1rewx - View Document
	genzyme_anzeige_290x60_2014-02-07_D_v02_em.indd DocID: 1pkK1 - View Document
	United States Court of Appeals for the Federal Circuit ______________________ GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP, DocID: 1oYEH - View Document
	IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE GENZYME CORPORATION and SANOFI-AVENTIS U.S. LLC, Plaintiffs/Counterclaim-Defendants, Plaintiffs, DocID: 1omGa - View Document